We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+11.08%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.67B
AUM Growth
-$254M
(-13%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-21.79%
Top 10 Holdings %
Top 10 Hldgs %
25.94%
Holding
1,700
New
415
Increased
295
Reduced
305
Closed
556
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Li Auto
LI
|
+$27.8M |
| 2 |
JD.com
JD
|
+$15.5M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$8.8M |
| 4 |
Canadian Solar
CSIQ
|
+$8.72M |
| 5 |
Trip.com Group
TCOM
|
+$7.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$21.4M |
| 2 |
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
|
+$14.6M |
| 3 |
KE Holdings
BEKE
|
+$14M |
| 4 |
STOR
STORE Capital Corporation
STOR
|
+$12.4M |
| 5 |
ONEM
1Life Healthcare
ONEM
|
+$12.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.68% |
| 2 | Consumer Discretionary | 12.97% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.28% |
| 5 | Healthcare | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Unisys
UIS
$211M
| $114K | 0.01% |
29,298
+17,754
| +154% | +$85.8K |
|
927
Cullinan Oncology
CGEM
$1.18B
| $113K | 0.01% |
11,044
-500
| -4% | -$5.51K |
|
928
Accel Entertainment
ACEL
$978M
| $113K | 0.01% |
12,378
-467
| -4% | -$4.2K |
|
|
TLIS
929
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $110K | 0.01% |
14,929
| – | – |
|
|
WBX
930
Wallbox
WBX
$79.6M
| $110K | 0.01% |
1,122
+208
| +23% | +$20.8K |
|
931
Nexa Resources
NEXA
$1.97B
| $109K | 0.01% |
+17,402
| New | +$113K |
|
932
Costamare
CMRE
$1.74B
| $108K | 0.01% |
+11,517
| New | +$114K |
|
|
LONA
933
LeonaBio Inc
LONA
$70.5M
| $107K | 0.01% |
4,296
-1,976
| -32% | -$63.6K |
|
934
OraSure Technologies
OSUR
$276M
| $107K | 0.01% |
17,700
| – | – |
|
935
Arhaus
ARHS
$1.34B
| $104K | 0.01% |
+12,571
| New | +$152K |
|
936
Achieve Life Sciences
ACHV
$685M
| $103K | 0.01% |
15,220
+3,375
| +28% | +$16K |
|
|
ARI
937
PUT
Apollo Commercial Real Estate
ARI
$871M
| $99.6K | 0.01% |
+10,700
| New | +$118K |
|
938
Jasper Therapeutics
JSPR
$26.6M
| $98.6K | 0.01% |
+5,450
| New | +$101K |
|
939
ADT
ADT
$5.49B
| $98.3K | 0.01% |
+13,600
| New | +$111K |
|
940
ARS Pharmaceuticals
SPRY
$587M
| $98K | 0.01% |
15,053
-1,436
| -9% | -$11K |
|
941
Seer Inc
SEER
$119M
| $96.1K | 0.01% |
+24,909
| New | +$115K |
|
|
CBAY
942
DELISTED
Cymabay Therapeutics
CBAY
| $95.7K | 0.01% |
+10,973
| New | +$87.8K |
|
943
Atea Pharmaceuticals
AVIR
$402M
| $95.5K | 0.01% |
+28,500
| New | +$116K |
|
944
Arbutus Biopharma
ABUS
$907M
| $94.5K | 0.01% |
31,199
-8,950
| -22% | -$25.2K |
|
945
Nordic American Tanker
NAT
$1.33B
| $92K | 0.01% |
+23,237
| New | +$83.3K |
|
946
RPC Inc
RES
$1.36B
| $90.6K | 0.01% |
+11,778
| New | +$105K |
|
947
The Honest Company
HNST
$561M
| $90K | 0.01% |
50,000
-5,449
| -10% | -$14.9K |
|
948
GoodRx Holdings
GDRX
$1.25B
| $89.7K | 0.01% |
14,356
-3,087
| -18% | -$17.2K |
|
|
OKUR
949
OnKure Therapeutics
OKUR
$164M
| $88.5K | 0.01% |
+1,480
| New | +$53.6K |
|
|
TWKS
950
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $86.7K | 0.01% |
+11,786
| New | +$109K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Prelude Capital Management held 1,700 positions worth $1.67B, down 13% from $1.92B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Prelude Capital Management withdrew a net $364M in Q1 2023, closing 556 positions and reducing 305 holdings. Its most notable exit was STORE Capital Corporation, an estimated $12.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Prelude Capital Management opened a new position in Li Auto worth $29.4M.
- Prelude Capital Management's largest Q1 2023 buy was Li Auto: 1,178,041 shares worth $29.4M.
- Prelude Capital Management added most to JD.com in Q1 2023, an estimated $15.5M increase.
- Prelude Capital Management's biggest Q1 2023 reduction was Alibaba, cutting an estimated $21.4M.
- Prelude Capital Management fully exited STORE Capital Corporation in Q1 2023, selling an estimated $12.4M.
- Prelude Capital Management's ten largest holdings make up 26% of its $1.67B portfolio in Q1 2023.
- Prelude Capital Management opened 415 new positions and closed 556 in Q1 2023.
- Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $1.67B.
Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.